Clinical Trial Update: Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating blinatumomab in adults with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive B-precursor Acute Lymphoblastic Leukemia

Drugs mentioned

• BLINCYTO (BLINATUMOMAB)

Snippet

Sponsor: Amgen | Conditions: Relapsed/Refractory Philadelphia Positive B-precursor ALL | Phase 2 | Status: COMPLETED | Results posted: 2017-08-09